March 28, 2011 (UPDATED April 5, 2011) — The US Food and Drug Administration (FDA) has approved the use of 3.75% imiquimod cream (Zyclara Cream) for the treatment of external anogenital warts in ...
A study has found that a cream commonly used for warts can also treat recurrent or secondary melanoma. The medication, known as DPCP, acts on the immune system to stimulate the body to kill the cancer ...
BRISTOL, Tenn.--(BUSINESS WIRE)-- Graceway® Pharmaceuticals announced today that the Food and Drug Administration (FDA) has approved Zyclara® Cream for the treatment of external genital and perianal ...
Two Phase III studies showed therapy using Zyclara resulted in 28.3% complete clearance rate. FDA has cleared Graceway® Pharmaceuticals’ once-daily Zyclara® 3.75% Cream (imiquimod) for the topical ...
A new study has pointed out an effective treatment for recurrent outbreaks of skin cancer. The cream contains the potent allergen diphencyprone (DPCP), and it is being used in an ongoing trial to ...
Airline travel got a little easier, if not less bureaucratic today, with the announcement that small amounts of toiletries could be put in your carry-on bag, if you separate them into small containers ...
A skin cream designed to treat genital warts is killing skin cancers so successfully there's rarely any need for surgery, a dermatologist told surgeons today. Sydney dermatologist Dr Stephen Shumack ...
Warts are noncancerous growths that develop on your skin or mucous membranes (soft, fleshy areas such as inside your mouth and genitals). They vary widely in shape and appearance — some are round, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results